Objective: The use of fully covered metal stents (FCMS) for the treatment of benign conditions is increasing. The aim of our study was to assess the efficacy of FCMS in the management of post-operative leaks after gastric or esophageal surgery.
INTRODUCTION
Surgery is the best curative treatment for patients with localized esophageal or gastric cancer, having a clear impact on survival. Nevertheless, gastric and especially esophageal resections are technically challenging procedures associated with morbidity and even mortality. Perioperative surgical complications are mainly due to anastomotic leaks described in 4-27% of patients after radical gastrectomy (1-3) and 5-18% after esophagectomy (4) (5) (6) . These complications are life-threatening medical emergencies and have a mortality rate up to 30% (2) . Minor leaks without sepsis can be managed conservatively but major disruptions require a risky reoperation with important hospital resources consumption and long hospitalization. In order to avoid surgical repairs, many endoscopic techniques such as clipping (7) or fibrin glue application (8) have been proposed as an alternative, with no proven efficacy.
Another endoscopic approach to this problem is the use of self-expandable stents. Several types of stents have been used, generally with good results. Self-expandable plastic stents (SEPS) were used first, presenting migration as their mayor complication (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ; partially covered self-expanding metal stent (PCMS) were also used with a mayor risk of developing hyperplastic inflammatory tissue through the open mesh of the stent making the removal of the stent difficult (19) (20) (21) (22) (23) (24) (25) . Subsequently, in an attempt to minimize these complications, fully covered self-expanding metal stents (FCMS) were developed. First reports about its use in benign conditions (including leaks, strictures or perforation) showed good results and a reasonable safety profile (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) .
The aim of our study was to assess the effectiveness of FCMS (Wallflex, Boston Scientific Corp. Nattick. Massachuset. United States) in the management of post-operative leaks after gastric or esophageal surgery.
MATERIAL AND METHODS

Patients
In a prospective study from January 2011 to December 2013, patients who underwent a surgery related with esophageal or gastric cancer in our institution and developed a postoperative anastomotic leak were prospectively eligible to be included in our study. All patients gave informed consent.
Diagnosis and treatment of anastomotic leak
Diagnosis of post-operative leak was made using water soluble contrast at day 5-7, according to our protocol (39) , or earlier in cases with clinical symptoms or radiological signs. All patients with signs of leak were endoscopically treated using FCMS. Patients remained in bed in decubitus position for 48 hours. After this period the effectiveness of leak occlusion and the absence of stent migration were evaluated by water soluble contrast swallow. In cases of therapeutic success, feeding was immediately started.
Stent retrieval was performed endoscopically 6-8 weeks after deployment, using also fluoroscopic control, with patients under general anesthesia to avoid risk of aspiration. Rat-tooth forceps was the most common used device, grasping at the proximal end of the stent and pulling out. Finally, complete closure of the leak was verified with radiological contrast study (Fig. 1) .
All endoscopic procedures were performed by two endoscopist, with experience in the use of enteral stents.
Demographic data (sex, age, indication of surgery, type of surgery -including laparoscopic or conventional approach-) were collected. Technical success was defined as the placement of the stent in the right location. Initial success was defined as absence of contrast extravasation after stent placement. Final success was defined as complete closure of leak after stent retrieval. Number of stents used, migration, need of relocation, and problems related to extraction were also analyzed. Finally, mortality and its relationship with initial diagnosis or stent complication were included.
RESULTS
The study includes 14 patients (11 men, 3 women) undergoing stent placement, with a median age of 65 years (range 46-77). Table I shows indication ant type of surgery; ten patients (71.5%) had been previously diagnosed of gastric cancer, and 4 patients (28.5%) with esophageal cancer. In one case surgery was performed with palliative intention (esophago-jejunal by pass).
Technical success was achieved in 13 patients (93%). The only case of failure was a patient with a complete anastomotic dehiscence where the identification of the efferent loop was impossible. Initial success was obtained in 12 of 13 patients (92.3%) in which stents were place. Final success was obtained in 9 of these cases (69.2%, intention to treat analysis; stent failed in one case (7.7%) and three patients due to death before stent retrieval (23.1%). These three deaths were not related to stent placement but to progression of the initial neoplasia. Ignoring these three deceased patients, final success was 90%.
In most of the cases only one stent was needed (69.2%) and in four cases two stents were necessary (30.8%) to obtain initial success. Migration was observed in two cases (15.3%) and relocation of the stent was possible in both patients. Table II shows case evolution. No major complications related to the use of stents, such as fistula, hemorrhage or perforation occurred. Only one patient referred pain after stent deployment.
Median of days between surgery and insertion of stent was 7 (limits 2-49). Median of days between initial insertion of the stent and retrieval was 44 (limits 12-101). No complications related to retrieval arouse.
Specific characteristics of individual cases are separately commented below: -Patient number 2 was the only technical failure due to a complete anastomotic dehiscence, needing urgent reoperation. -Patient number 3 had the upper limit of stent deployment (day 49) due to late presentation of clinical signs of fistula; this patient was also the case with an earlier stent withdrawal due to chest pain (day 12 after insertion). Notwithstanding, a complete closure of the leak was achieved. -In patient number 7, retrieval of the stent was performed substantially later compared to the rest of cases (101 days). This discrepant result was due to a severe clinical decompensation of a cardiac disorder delaying the procedure. -In patient number 14, initial and final success was achieved. During the period with the stent placed, the patient presented a hypovolemic shock due to an acute hemorrhage originated in an aneurism of the hepatic artery, treated with insertion of coils by a radiologist. Three months after stent retrieval, migration of coils to jejunum adjacent to the anastomosis was observed, causing a new fistula (Fig.  2 ). Coils were endoscopically retrieval, and a new FCMS was placed also with initial good result. Nevertheless, when stent was retrieval 9 weeks later, persistence of the fistula was observed; then a surgical approach was performed, finding neoplastic local recurrence.
DISCUSSION
In this study we describe our three-year's experience with FCMS for treatment of post-operative leaks in patients with esophageal or gastric cancer. The use of stents for the treatment of benign esophageal conditions such as strictures, post-surgical leaks, iatrogenic or spontaneous perforations is widespread. Nevertheless, the availability of different types of stents may induce doubt which is the best option in each situation (uncovered, partially covered or fully covered metallic or plastic). At the time of the beginning of our study there were no published reports comparing them. Our decision of using FCMS was based on the following criteria. Uncovered metallic stents become embedded into the gut wall and retrieval might be extremely or even impossible. SEPS avoid this risk, but present high rates of migration up to 40% (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) in relation to the absence of a uncovered portion and with low radial force. PCMS combine good radial force with an inner silicone membrane that prevents the growth of tissue through the mesh except at their ends; nevertheless, the uncovered portion may also strongly anchor to the wall and safe removal may be complicated (40) with high rates of perforation. To facilitate removal of PCMS, the stent-instent technique (placing a SEPS inside the partially covered stent, and removing both stents in two weeks) can be used with good efficacy (41) but increasing the costs significantly. Theoretically, FCMS should not get embedded, should have enough force to reduce migration rate and, from our point of view, the introduction system is simpler than plastic stent delivery, likewise, the retrieval of stent is easier too.
Initial publications about FCMS show good results, with leaks closure ranging from 38% to 100% (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . However the interpretation of these results is complex because studies are heterogeneous, most of them also include malign and benign conditions, and different clinical situations (such as leaks, fistulas, stenosis or iatrogenic perforations) are analyzed together. In addition, different types of FCMS are included in these studies (Hanaro stent, ELLA stent, Alimaxx stent or Wallflex stent); for example, first reports about Wallflex dated from 2011 (30) and 2012 (31) . Our results of initial and final success show great efficacy of our approach, similar to the best series published.
The choice of fully covered stents as treatment was subsequently endorsed by two comparative studies using different types of stents. Van Boeckel et al. (42) compared the efficacy of FCMS, PCMS and SEPS with slight increase of leak closure in the FCMS (83%) and plastic stents (83%) groups, versus 73% in the PCMS group. Main differences were found regarding migration rates (worse fully covered stents) and tissue in-or overgrowth (exclusively in partially covered stents). Gangloff et al. (43) reported greater long term clinical efficacy of FCMS (34.7%) versus PCMS (23.5%), without differences in migration rate. In a systematic review, stent migration occurred in 26% of patients with FCMS and 31% with SEPS (44). Main concern about FCMS is the risk of migration, reported in up to 44% (27) , although in most series it is about 20-30%. In order to reduce this problem, as we made previously (39) , wider diameter stents were used to occlude completely the esophageal lumen obtaining a stronger anchor. Also, 48 hours in decubitus position was recommended to complete expansion of the stent. We cannot conclude that these two maneuvers are especially effective, but our migration rate is really low (13%), without complications related, and easy repositioning. Difficult in stent retrieval and severe tissue reactions were not found in our patients, in contrast to other series (31, 33, 36 (42) . In our opinion, retrieval of the stent should not be performed before 4 weeks (ideally 6-8 weeks), in order to ensure closure of the leak, though it is a factor that does not seem to influence the risk of migration.
We found no difficulty in removal of stents, even in cases with periods of stent permanence longer than median. In the largest series published with FCMS (34) which included 59 patients (22 of them anastomotic leaks), stent-induced granulation tissue was described in 12 cases (20%). The mean duration of stent placement in these 12 cases was higher than in the median of all patients (88 versus 67 days), but all of them were successfully removed without complications.
According to our experience, the placement of FCMS is a good alternative in the treatment of postoperative leaks with minor risks, avoiding open reoperation in mostly of cases. Other potential include reducing the in-hospital stay and allowing early oral intakes. A low migration rate can be achieved, considering the size of the stent as one of the factors potentially involved. One advantage of our data is that we only describe, in contrast to most, post-surgical leaks in patients with esophageal or gastric cancer avoiding confounding etiologies. Major limitations are the absence of a control group, and being a single center study with a limited number of cases. Other main limitation is the fact that a single type of FCMS was used. A comparison between different types might be interesting and would provide more robust results.
In conclusion, the placement of FCMS to achieve the leak closure after esophageal or gastric surgery is an effective and probably, feasible without major complications, that could be considered in all cases.
